1. Efficacy and safety of a single‐tablet regimen containing tenofovir disoproxil fumarate 300 mg, lamivudine 300 mg and efavirenz 400 mg as a switch strategy in virologically suppressed HIV‐1‐infected subjects on nonnucleoside reverse transcriptase inhibitor‐containing first‐line antiretroviral therapy in Pune, India. Issue 9 (20th July 2020) Authors: Dravid, A; Betha, TP; Sharma, AK; Gawali, R; Mahajan, U; Kulkarni, M; Saraf, C; Kore, S; Dravid, M; Rathod, N Journal: HIV medicine Issue: Volume 21:Issue 9(2020) Page Start: 578 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗